Booster shot for meningitis b shows promise in teens
NCT ID NCT06995430
First seen Nov 24, 2025 · Last updated May 17, 2026 · Updated 15 times
Summary
This study looked at how well a booster dose of the meningitis B vaccine works in healthy people aged 10 to 20 who got the vaccine as babies. Researchers compared their immune response to those who never had the vaccine. The goal was to see if the booster provides strong protection against meningitis B.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Espoo, 02230, Finland
-
GSK Investigational Site
Helsinki, 00100, Finland
-
GSK Investigational Site
Jarvenpaa, 04400, Finland
-
GSK Investigational Site
Kokkola, 67100, Finland
-
GSK Investigational Site
Oulu, 90220, Finland
-
GSK Investigational Site
Seinäjoki, 60100, Finland
-
GSK Investigational Site
Tampere, 33100, Finland
-
GSK Investigational Site
Turku, 20520, Finland
-
GSK Investigational Site
Florence, 50139, Italy
-
GSK Investigational Site
Genova, 16132, Italy
-
GSK Investigational Site
Milan, 20122, Italy
-
GSK Investigational Site
Novara, 28100, Italy
-
GSK Investigational Site
Santiago de Compostela, 15701, Spain
-
GSK Investigational Site
Seville, 41014, Spain
-
GSK Investigational Site
Bristol, BS2 8BJ, United Kingdom
-
GSK Investigational Site
London, SW17 0RE, United Kingdom
-
GSK Investigational Site
Oxford, OX3 7LE, United Kingdom
Conditions
Explore the condition pages connected to this study.